baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Tonix Pharmaceuticals Holding Cor.../ US8902608541 /

17/05/2024 21:59:49	Chg. +0.02	Volume	Bid-	Ask-	High	Low
0.20USD	+8.28%	42,191 Turnover: 8,485.75	-Bid Size: -	-Ask Size: -	0.21	0.19

GlobeNewswire 15/05 Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

GlobeNewswire 13/05 Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 24/04 Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase

GlobeNewswire 01/04 Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Hi...

GlobeNewswire 28/03 Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

GlobeNewswire 25/03 Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...

GlobeNewswire 21/03 Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Ox...

GlobeNewswire 20/03 Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch...

GlobeNewswire 19/03 Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on...

GlobeNewswire 12/03 Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

GlobeNewswire 11/03 Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonm...

GlobeNewswire 07/03 Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-1...

GlobeNewswire 06/03 Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of...

GlobeNewswire 05/03 Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (F...

GlobeNewswire 29/02 Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in F...

GlobeNewswire 28/02 Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized ...

GlobeNewswire 27/02 Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Ton...

GlobeNewswire 20/02 Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference

GlobeNewswire 15/02 Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

GlobeNewswire 14/02 Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans t...

GlobeNewswire 13/02 Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Applicati...

GlobeNewswire 12/02 Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reducti...

GlobeNewswire 29/01 Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for t...

GlobeNewswire 25/01 Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored...

GlobeNewswire 09/01 Tonix Pharmaceuticals Presents Additional Data Highlighting the Favorable Tolerability and Different...

Tonix Pharmaceuticals Holding Cor.../ US8902608541 /

If you wish to receive reply to your feedback, please provide your email address.